SEARCH RESULT

Total Matching Records found : 300

Why do Indian health authorities keep quiet on pharma firms' failings? -Nivedita Mookerji

-Business Standard Domestic regulators need to be stricter about quality violations to protect both Indian pharma exports as well as the country's image Even as major Indian drug companies continue to make news for impurities in the medicines they make and faulty - or if the USFDA is to be believed, falsified - data that many generate after testing of samples show quality problem, it seems strange that domestic authorities are silent...

More »

All new medicines to come under price control -Sushmi Dey

-The Times of India NEW DELHI: The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as 'new medicines'. The move is aimed at spanning the...

More »

MNCs deprive India of vital drugs -Rupali Mukherjee

-The Times of India MUMBAI: Some multinational companies (MNCs) have been delaying the launch of life-saving drugs in India years after getting monopoly rights, while cheaper generic versions of exorbitantly-priced medicines are going off the shelves under the product patenting law. Corporates such as Japanese firm Otsuka Pharmaceuticals, US-based Bristol Myers-Squibb (BMS) and Swiss firm Novartis are deferring the launch of medicines critical for treatment of serious non-communicable diseases like cancer, HIV,...

More »

Billing for wallet shock -Digbijay Mishra

-Business Standard Indian and other generic drug firms face prospect of US legislature debating compensation for undue price rises Indian generic drug makers might, if a proposed US law comes about, need to pay a rebate to the federal Medicaid programme there when prices of their medications outpace inflation. A Bill is to be introduced in the US Senate by a member, aimed to cushion the impact on taxpayers in this manner...

More »

Drug prices to go up as govt bans PET medicine bottles, is ban based on data?

-The News Minute The use of plastic or polyethylene terephthalate (PET) bottles for packaging medicines such as syrups and liquid orals has been banned by the government. Reports say that this ban will lead a price hike for certain drugs meant for children, women and senior citizens. According to a Times of India report SV Veeramani, president, Indian Drug Manufacturers Association (IDMA) confirmed the move, "There would be estimated 25-30% cost increase...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close